Mercer Investments Acquires Stake in Microba Life Sciences

Microba Life Sciences Limited (AU:MAP) has released an update.

Don't Miss Our New Year's Offers:

Mercer Investments (Australia) Limited, through its Mercer Australian Small Companies Fund, has acquired a substantial holding in Microba Life Sciences Ltd, amounting to a 5.033% voting power with over 22 million shares. This move positions Mercer as a significant investor in the biotech company, reflecting confidence in Microba’s growth potential within the life sciences sector.

For further insights into AU:MAP stock, check out TipRanks’ Stock Analysis page.

Trending Articles

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tags

More Related Articles

Info icon

This data feed is not available at this time.

Data is currently not available

Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education. Delivered Wednesdays.